ABSTRACT
Trade name: Ubretid (Sanofi) Indications: Post-operative urinary retention. Post operative ileus and intestinal atony. Adjunct in the treatment of Myasthenia gravis. Category: Acetylcholine inhibitor Half-life: N/A Clinically important, potentially hazardous interactions with: beta-blockers, local anesthetics, muscle relaxants
